Last edition
News about
Agilent Advances Sustainable Science with New India Refurbishment Centre
Agilent Technologies has inaugurated a new refurbishment centre in India, reinforcing its commitment to sustainable science and affordable innovation while enhancing customer engagement through an integrated, green-certified facility that also houses a dedicated education centre.
Lupin Secures Positive CHMP Opinion for Ranibizumab Biosimilar
Lupin has received a positive opinion from the CHMP for its ranibizumab biosimilar, supported by comprehensive analytical similarity data and a global Phase III clinical trial involving 600 patients with neovascular Age-related Macular Degeneration (AMD).
Indian Pharma Exports Rise Over Nine Percent in 2024-25: Government
India’s pharmaceutical exports recorded strong growth in the 2024–25 financial year, increasing by over nine percent to about USD 30.47 billion, according to government data.
US FDA Places Sun Pharma's Baska Facility Under 'Official Action Indicated' After Inspection
Sun Pharmaceutical Industries Ltd said the U.S. Food and Drug Administration (FDA) has assigned an “Official Action Indicated” (OAI) status to its Baska manufacturing facility following a recent regulatory inspection.
INCOG BioPharma Announces USD 200 Million Expansion
INCOG BioPharma has announced a USD 200 million expansion aimed at significantly increasing its injectable drug product manufacturing capacity, with plans to grow its workforce to nearly 1,000 employees at its Fishers campus by 2030.
Revvity Launches AI Platform for Molecular and Materials Discovery
Revvity has launched a new AI-powered Models-as-a-Service (MaaS) platform designed to integrate in-silico molecular and materials design with experimental data, enabling continuous learning, improved predictive accuracy, and faster scientific discovery.
Merck Launches ChemiSphere App to Streamline Digital Data Access and Enhance Lab Efficiency
Merck has launched the ChemiSphere app to streamline digital data access and improve lab efficiency by linking physical products with secure digital workflows, enabling quick access to key documentation such as SDS and CoA.
US FDA Issues EIR with VAI Classification to Lupin's Nagpur Injectables Plant
Global pharmaceutical major Lupin Limited (Lupin) has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its injectable manufacturing facility located in Nagpur, India.
Glenmark Secures Exclusive Multi-Region Rights to Aumolertinib from Hansoh Pharma
Glenmark has entered into an exclusive licensing agreement with Hansoh Pharma to commercialise aumolertinib, a third-generation EGFR-TKI approved by the MHRA and China’s NMPA, across multiple international markets, reinforcing the company’s oncology portfolio and expansion strategy in high-growth regions.
TempraMed Secures South Korea Patent for VIVI Box Medication Storage Technology
TempraMed Technologies Ltd, a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, announced that it has been granted an additional allowed patent in South Korea, issued under Korean Patent Application No. 10-2021-7011422.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy